{"id":"W3204658474","doi":"10.1016/j.annonc.2021.08.1962","title":"1361TiP Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC): A phase (ph) II study (DESTINY-Lung02)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Metastatic breast cancer; Refractory (planetary science); Oncology; Lung cancer; Cancer; non-small cell lung cancer (NSCLC); Antibody-drug conjugate; Antibody; Breast cancer; Monoclonal antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004686572,0.0006818817,0.0009756316,0.0001834064,0.0001787324,0.0005965178,0.0003468119,0.000510245,0.002631211],"category_scores_gemma":[0.0004420674,0.0002856015,0.0005657513,0.0002569155,0.0003081306,0.0003898002,0.0002300415,0.001117231,0.0005288714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006476964,"about_ca_system_score_gemma":0.0007410393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001406701,"about_ca_topic_score_gemma":0.004333849,"domain_scores_codex":[0.9998211,0.00007759201,0.000008409856,0.00003193304,0.00001566498,0.00004533678],"domain_scores_gemma":[0.9998308,0.00003039161,0.00002594391,0.00001023886,0.00001079282,0.00009163008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6575473,0.02143591,0.03752525,0.0005863907,0.001784245,0.0002993508,0.0002160633,0.003106125,0.05115966,0.0002445073,0.006226431,0.2198689],"study_design_scores_gemma":[0.5103267,0.3725818,0.09879279,0.00006331595,0.00118481,0.0005463792,0.0001149289,0.002540993,0.006490748,0.0001821097,0.007136889,0.00003858909],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996053,0.001405209,0.0001177176,0.0002411691,0.00005957779,0.0002623974,0.0005614209,0.00003576596,0.001263661],"genre_scores_gemma":[0.9938212,0.001350087,0.0003475919,0.0003631293,0.00007014123,0.0002125214,0.001765439,0.00001196632,0.002057889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002631211,"threshold_uncertainty_score":0.008802295,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09043951009908645,"score_gpt":0.4486056378400373,"score_spread":0.3581661277409509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}